Replidyne (RDYN)

[surf1944]

RDYN has bottomed and you should get a nice bounce into CC: (buy on any further weakness)

Replidyne to Report 2007 Fourth Quarter and Year-End Earnings
Tuesday February 5, 7:30 am ET
Presenting at BIO CEO & Investor Conference

LOUISVILLE, Colo., Feb. 5 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN - News) announced today that it will host a conference call on Tuesday, February 26, 2008 at 4:45 P.M. ET to report 2007 fourth quarter and year-end earnings. Additionally, Replidyne will present at an upcoming investor conference in February 2008.

Earnings conference call information is as follows:

Kenneth J. Collins, President and CEO, and other members of Replidyne's
senior management team will provide a company update and discuss
earnings results via conference call and webcast on Tuesday, February 26,
2008, at 4:45 P.M. ET. Callers may participate in the conference call by
dialing 866-510-0707 (domestic) or 617-597-5376 (international), and
providing the passcode 33794809. To access the live webcast, please log
on to the company's website at http://www.Replidyne.com and go to the
Investor Relations section.

A replay of the conference call will be available approximately one hour
after completion of the call through Tuesday, March 11, 2008 at midnight.
Callers may access the replay by dialing 888-286-8010 (U.S.
participants) or 617-801-6888 (international participants). The audio
replay passcode is 92464480. To access a replay of the webcast, visit
the Investor Relations section of the company's website at
http://www.Replidyne.com.


Investor conference presentation information is as follows:

-- Mr. Collins will present on Tuesday, February 12, 2008 at 2:45 P.M. ET
at the BIO CEO & Investor Conference, to be held at the Waldorf-Astoria
in New York City. A live audio webcast of this presentation will be
available on the investor relations section of the company's website at
http://www.Replidyne.com. The webcast will be archived and available on
Replidyne's website after the event for a period of 30 days.
-- At the same conference, Replidyne's Chief Commercial Officer Peter
Letendre, Pharm.D. will participate on antibiotics panel "Super Drugs
Against Super Bugs" on Wednesday, February 13, 2008 at 9:30 A.M.